Major Rating Factors:
Poor long-term capitalization index (0.7 on a scale of 0 to 10) based on weak current risk adjusted capital (severe and moderate loss scenarios), although results have slipped from the fair range during the last year. A history of deficient reserves (1.5) that places pressure on both capital and profits. Deficiencies in the two year reserve development occurred in three of the previous five years and ranged between 28.5% and 52.8%. Weak profitability index (1.1) with operating losses during 2023, 2024 and 2025.
Other Rating Factors:
Weak overall results on stability tests (2.3) including weak results on operational trends, negative cash flow from operations for 2025 and fair risk adjusted capital in prior years. Good liquidity (5.6) with sufficient resources (cash flows and marketable investments) to handle a spike in claims.
Stability Factors:
C - Past results on our Risk-Adjusted Capital tests.
D - Limited diversification of general business, policy, and/or investment risk.
F - Negative cash flow.
R - Concerns about the financial strength of its reinsurers.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (100.0%)
Licensed in:
FL, MD, NJ, OH, PA, SC, WV
Principal Investments:
Investment grade bonds (78.6%), common stock (15.8%), cash (5.6%)
Corporate Info
Group Affiliation
None
Investment Rating
--
Company Address
41909 Route 6
Wyalusing, PA 18853
Wyalusing, PA 18853
Phone Number
(570) 746-9429
NAIC Number
11694
Website
Largest Affiliates
There are no affiliate to display.